Musculoskeletal Flashcards

Conditions and presentation

1
Q

What rules are used to assess ankle injuries

A

Ottawa ankle rules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ottawa rules and X-rays rule

A
  1. Inability to weight bear for 4 steps
  2. Tenderness over the distal tibia
  3. Bone tenderness over the distal fibula
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ankle fracture scales

A
  • Potts
  • Weber
  • AO systems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Weber classifications

A
  • Type A below the syndesmosis
  • Type B start at the level of the plafond and extends to involve syndemosis
  • Type C is above sysndesmosis and causes damage to it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of ankle injury

A

*promptly remove and reduce pressure to overlying skin
*young patients usually require surgery
* Elderly patients fare better with conservative management as their bones may not support metal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discitis

A

*Infection in the intervertebral disc space.
*Leads to serious complications such as sepsis or epidural abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Features of Discitis

A
  • Back pain

General features
* pyrexia
* rigors
* sepsis

Neurological features
* e.g. changing lower limb neurology
* if an epidural abscess develops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of discitis

A

Bacterial
Staphylococcus aureus is the most common cause of discitis
Viral
TB
Aseptic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of discitis

A

Imaging: MRI has the highest sensitivity
CT-guided biopsy may be required to guide antimicrobial treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Managment of discitis

A
  • six to eight weeks of intravenous antibiotic therapy (IV co amox)
  • the patient should be assessed for endocarditis e.g. with transthoracic echo or transesophageal echo.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Red flags for lower back pain (5)

A
  • age < 20 years or > 50 years
  • history of previous malignancy
  • night pain
  • history of trauma
  • systemically unwell e.g. weight loss, fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Facet Joint pain

A
  • pain between bones of spine
  • May be acute or chronic
  • Pain worse in the morning and on standing
  • On examination there may be pain over the facets. The pain is typically worse on extension of the back
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Spinal stenosis

A
  • Usually gradual onset
  • Unilateral or bilateral leg pain (with or without back pain), numbness, and weakness which is worse on walking. Resolves when sits down. Pain may be described as ‘aching’, ‘crawling’.
  • Relieved by sitting down, leaning forwards and crouching down
  • Clinical examination is often normal
  • Requires MRI to confirm diagnosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ankylosing Spondylitis

A
  • Typically a young man who presents with lower back pain and stiffness
  • Stiffness is usually worse in morning and improves with activity
  • Peripheral arthritis (25%, more common if female)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Peipheral artery disease: when to suspect

A
  • Pain on walking, relieved by rest
  • Absent or weak foot pulses and other signs of limb ischaemia
  • Past history may include smoking and other vascular diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lumbar spinal stenosis

A

central canal is narrowed by tumour, disk prolapse or other similar degenerative changes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Symptoms of Lumbar spinal Stenosis

A
  • back pain, neuropathic pain and symptoms mimicking claudication.

*Sitting is better than standing and patients may find it easier to walk uphill rather than downhill.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pathology of spinal stenosis

A
  • Intervertebral disk where biochemical changes such as cell death and loss of proteoglycan and water content lead to progressive disk bulging and collapse.
  • Increased stress transfer to the posterior facet joints, which accelerates cartilaginous degeneration, hypertrophy, and osteophyte formation; this is associated with thickening and distortion of the ligamentum flavum.
  • ventral disk bulging, osteophyte formation at the dorsal facet, and ligamentum flavum hyptertrophy combine to circumferentially narrow the spinal canal and the space available for the neural elements. The compression of the nerve roots of the cauda equina leads to the characteristic clinical signs and symptoms of lumbar spinal stenosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Investigation of spinal stenosis

A

MRI scanning is the best modality for demonstrating the canal narrowing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment of spinal stenosis

A

Laminectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Neoplastic spinal cord compression

A
  • Oncological emergency
  • affects up to 5% of cancer patients.
  • Extradural compression accounts for the majority of cases, usually due to vertebral body metastases.
  • It is more common in patients with ** lung, breast and prostate cancer **
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Features of Neoplastic spinal cord compression

A

1* back pain
* the earliest and most common symptom
* may be worse on lying down and coughing
* lower limb weakness
* sensory changes: sensory loss and numbness
* neurological signs depend on the level of the lesion.

Above L1 upper motor neurone signs
Below L1 lower motor neurone signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Investigations of Spinal cord compression

A

urgent MRI: the 2019 NICE guidelines recommend a whole MRI spine within 24 hours of presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Managment of spinal cord compression

A
  • high-dose oral dexamethasone
  • urgent oncological assessment for consideration of radiotherapy or surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Managment of Osteomyelitis
* flucloxacillin for 6 weeks * clindamycin if penicillin-allergic
26
Investigations for Osteomylitis
MRI is the imaging modality of choice, with a sensitivity of 90-100%
27
non-haematogenous osteomyelitis
* results from the contiguous spread of infection from adjacent soft tissues to the bone or from direct injury/trauma to bone * is often polymicrobial * most common form in adults * risk factors include: diabetic foot ulcers/pressure sores, diabetes mellitus, peripheral arterial disease
28
haematogenous osteomyelitis
* results from bacteraemia * is usually monomicrobial * most common form in children * vertebral osteomyelitis is the most common form of haematogenous osteomyelitis in adults * risk factors include: sickle cell anaemia, intravenous drug user, immunosuppression due to either medication or HIV, infective endocarditis
29
Ankylosing spondylitis
HLA-B27 associated spondyloarthropathy. It typically presents in males (sex ratio 3:1) aged 20-30 years old.
30
Prescribing methotrexate
- take once a week - folate in meantime
31
Features of ankylosing spondylitis
*typically a young man who presents with lower back pain and stiffness of insidious onset *stiffness is usually worse in the morning and improves with exercise *the patient may experience pain at night which improves on getting up
32
Clinical examination of ankylosing spondylitis
*reduced lateral flexion *reduced forward flexion - Schober's test - a line is drawn 10 cm above and 5 cm below the back dimples (dimples of Venus). The distance between the two lines should increase by more than 5 cm when the patient bends as far forward as possible *reduced chest expansion
33
The A’s of ankylosing spondylitis (8)
Apical fibrosis Anterior uveitis Aortic regurgitation Achilles tendonitis AV node block Amyloidosis and cauda equina syndrome peripheral arthritis (25%, more common if female)
34
treatment of ankylosing spondylitis
* exercise * smoking cessation * NSAIDs * physiotherapist * disease-modifying drugs which are used to treat rheumatoid arthritis (such as sulphasalazine) are only really useful if there is peripheral joint involvement * Anti-TNF therapy ( adalimumab, etanercept)
35
Indications for methotrexate
inflammatory arthritis, especially rheumatoid arthritis psoriasis some chemotherapy acute lymphoblastic leukaemia
36
Adverse affects of methotrexate (5)
mucositis myelosuppression pneumonitis Pulmonary fibrosis Liver fibrosis
37
Pregnancy and methotrexate
* women should avoid pregnancy for at least 6 months after treatment has stopped * men using methotrexate need to use effective contraception for at least 6 months after treatment
38
Rheumatoid arthritis
* Rheumatoid arthritis (RA) is a chronic autoimmune disorder that primarily affects the joints, causing inflammation, pain, stiffness, and potential joint damage.
39
Rheumatoid arthritis surgical sieve
*autoimmune condition * immune system mistakenly attacking healthy tissues, particularly the synovium, the lining of the joints.
40
Symptoms of rheumatoid arthritis
include joint pain, swelling, stiffness, fatigue, and warmth around affected joints. Symptoms often occur symmetrically, affecting both sides of the body.
41
What joints does RA affect?
RA typically affects small joints first, such as those in the hands and feet, but can progress to larger joints like knees, shoulders, and hips.
42
Disease-Modifying Antirheumatic Drugs (DMARDs)
methotrexate and sulfasalazine,
43
*TNF-alpha inhibitors (e.g., adalimumab, etanercept) *interleukin-6 (IL-6) inhibitors (e.g., tocilizumab), *specifically target parts of the immune system involved in RA.
44
extrarticular features of RA
*cardiovascular disease *lung problems (e.g., interstitial lung disease), *osteoporosis * increased risk of infections.
45
respiratory complications of RA (6)
* pulmonary fibrosis * pleural effusion * pulmonary nodules * bronchiolitis obliterans * methotrexate pneumonitis * pleurisy
46
Occular manifestations of RA (7)
* keratoconjunctivitis sicca (most common), * episcleritis * scleritis * corneal ulceration * keratitis * steroid-induced cataracts * chloroquine retinopathy
47
Cardiac complications of RA
Ischaemic heart disease | RA carries a similar risk to type 2 diabetes mellitus
48
Felty's syndrome | less common ## Footnote three components
RA + splenomegaly + low white cell count ## Footnote amyloidoisis is also less common (not
49
RA diagnosis
1) have at least 1 joint with definite clinical synovitis 2) with the synovitis not better explained by another disease Classification criteria for rheumatoid arthritis (add score of categories A-D; a score of 6/10 is needed definite rheumatoid arthritis)
50
RA antibodies
* Rheumatoid factor (RF) is a circulating antibody (usually IgM) that reacts with the Fc portion of the patients own IgG **RF can be detected by either** * Rose-Waaler test: sheep red cell agglutination * Latex agglutination test (less specific)
51
RF associated with positive RF (7)
* Felty's syndrome (around 100%) * Sjogren's syndrome (around 50%) * infective endocarditis (around 50%) * SLE (= 20-30%) * systemic sclerosis (= 30%) * general population (= 5%) * rarely: TB, HBV, EBV, leprosy
52
Anti-cyclic citrullinated peptide antibody
* Anti-cyclic citrullinated peptide antibody may be detectable up to 10 years before the development of rheumatoid arthritis.
53
RA xrays
x-rays of the hands and feet of all patients with suspected rheumatoid arthritis.
54
Initial therapy managment of RA
* DMARD monotherapy +/- a short-course of bridging prednisolone DMARD options include: * methotrexate * sulfasalazine * leflunomide * hydroxychloroquine
55
Moinitoring in patients who take **Methotrexate**
* FBC & LFTs | due to the risk of myelosuppression and liver cirrhosis
56
RA monitoring response to treatment
* DAS28 * CRP and disease
57
Managment of RA flares
flares of RA are often managed with corticosteroids - oral or intramuscular
58
When to use TNFs
inadequate response to at least two DMARDs including methotrexate
59
Rituximab
anti-CD20 monoclonal antibody, results in B-cell depletion two 1g intravenous infusions are given two weeks apart infusion reactions are common
60
Abatacept
* fusion protein that modulates a key signal required for activation of T lymphocytes * leads to decreased T-cell proliferation and cytokine production * given as an infusion * not currently recommend by NICE
61
Managment of RA in pregnancy
* sulfasalazine and hydroxychloroquine are considered safe in pregnancy * low dose coritcosteroids * referred to an obstetric anaesthetist due to the risk of atlanto-axial subluxation * NSAIDs up to 32 weeks (early closure of ductus arteriosus) ## Footnote most patient RA will resolve in pregnancy
62
Features of RA
* swollen, painful joints in hands and feet * stiffness worse in the morning * gradually gets worse with larger joints becoming involved * presentation usually insidiously develops over a few months * positive 'squeeze test' - discomfort on squeezing across the metacarpal or metatarsal joints * acute onset with marked systemic disturbance * relapsing/remitting monoarthritis of different large joints (palindromic rheumatism)
63
Poor prognostic features of RA
* rheumatoid factor positive * anti-CCP antibodies * poor functional status at presentation * X-ray: early erosions (e.g. after < 2 years) * extra articular features e.g. nodules * HLA DR4 * insidious onset
64
X-ray feature changes in RA
* loss of joint space * juxta-articular osteoporosis * soft-tissue swelling * periarticular erosions * subluxation
65
causes of septic arthritis
* Staphylococcus aureus * Neisseria gonorrhoeae (sexually active) * hematogenous spread this may be from distant bacterial infections e.g. abscesses
66
Features of septic arthritis
* acute, swollen joint * restricted movement in 80% of patients * examination findings: warm to touch/fluctuant * fever: present in the majority of patients
67
Investigations for septic arthritis
* synovial fluid sampling is obligatory * this should be done prior to the administration of antibiotics if necessary * may need to be done under radiographic guidance * blood cultures: the most common cause of septic arthritis is hematogenous spread * joint imaging
68
Managment of Septic arthritis
* Intravenous antibiotics which cover Gram-positive cocci are indicated. * flucloxacillin or clindamycin if penicillin allergic * needle aspiration should be used to decompress the joint arthroscopic lavage may be required
69
Paediatric Kocher criteria | for sepric arthritis diagnosis
* fever >38.5 degrees C * non-weight bearing * raised ESR * raised WCC
70
Investigations for paediatric septic arthritis
* joint aspiration: for culture. Will show a raised WBC * raised inflammatory markers * blood cultures
71
Signs of paediatric septic arthritis
* swollen, red joint * typically, only minimal movement of the affected joint is possible
72
Symptoms of Paediatric septic arthritis
* joint pain * limp * fever * systemically unwell: lethargy
73
Joints affected in paediatric septic arthritis
hip, knee and ankle.
74
Epidemiologyof septic arthritis in Paeds
* has an incidence of around 4-5 per 100,000 children * more common in boys, M:F ratio = 2:1
75
what is this?
Rheumatoid arthritis * swan-neck deformity * boutonniere deformity * Z-thumb deformity. * soft tissue swelling
76
what is this?
Osteoarthritis
77
Epidemiology of Osteoarthritis
* There may be a positive family history * More commonly affects women (M:F 1:3) * Rare to present before 55 years of age * Radiologic signs are more common than symptoms * The presence of hand OA increases the risk of future hip and knee OA (higher for hip OA than for knee OA)
78
Risk factors of OA (5)
* Previous trauma of a joint increases the risk of having OA in that joint * Obesity * Hypermobility of a joint increases the risk of OA in that joint * Occupation e.g. cotton workers and farmers are more susceptible to hand OA * Osteoporosis reduces the risk of OA
79
Nodes in OA
Heberden's nodes at the DIP joints Bouchard's Nodes at the PIP joints
80
Features of OA
* Usually bilateral * Episodic joint pain: An intermittent ache. * Stiffness * worse after long periods of inactivity e.g. waking up in the morning * stiffness lasts a few moments * painless nodules * squaring of joints * usually no functional issues (may be reduced stregth)
81
OA signs
* Stiffness * worse after long periods of inactivity e.g. waking up in the morning
82
DDX of polyarthritis (8)
* Rheumatoid arthritis * SLE * seronegative spondyloarthropathies * Henoch-Schonlein purpura * sarcoidosis * tuberculosis * pseudogout * viral infection: EBV, HIV, hepatitis, mumps, rubella
83
Psoriatic arthropathy
inflammatory arthritis associated with psoriasis and is classed as one of the seronegative spondyloarthropathies. relates poorly with cutaneous psoriasis and often precedes the development of skin lesions.
84
Patterns of PA
* symmetric polyarthritis * very similar to RA * 30-40% of cases, most common type * **asymmetrical oligoarthritis**: typically affects hands and feet (20-30%) * sacroiliitis * DIP joint disease (10%) * arthritis mutilans (severe deformity fingers/hand, 'telescoping fingers') * psoriatic skin lesions * periarticular disease - tenosynovitis and soft tissue inflammation resulting in: * enthesitis: inflammation at the site of tendon and ligament insertion e.g. Achilles tendonitis, plantar fascitis * tenosynovitis: typically of the flexor tendons of the hands * dactylitis: diffuse swelling of a finger or toe * nail changes * pitting * onycholysis
85
PA investigations
**X-ray** often have the unusual combination of coexistence of erosive changes and new bone formation periostitis 'pencil-in-cup' appearance
86
PA managment
* should be managed by rheumatologist * mild disease- NSAID * moderate/severe disease then methotrexate is typically used * **ustekinumab** (targets both IL-12 and IL-23) and **secukinumab** (targets IL-17) * **apremilast**: phosphodiesterase type-4 (PDE4) inhibitor → suppression of pro-inflammatory mediator synthesis and promotion of anti-inflammatory mediators
87
Cleft lip palate
affect around 1 in every 1,000 babies recognised component of more than 200 birth defects.
88
Common variations of cleft lip palate
isolated cleft lip (15%) isolated cleft palate (40%) combined cleft lip and palate (45%)
89
Pathophysiology of cleft lip palate
polygenic inheritance maternal antiepileptic use increases risk cleft lip results from failure of the fronto-nasal and maxillary processes to fuse cleft palate results from failure of the palatine processes and the nasal septum to fuse
90
Problems with cleft lip palate
feeding: orthodontic devices may be helpful speech: with speech therapy 75% of children develop normal speech increased risk of otitis media for cleft palate babies
91
management of cleft lip and cleft palate
Cleft lip: Surgical repair in first week of life to theee months Cleft palates repaired in 6-12 months
92
Developmental dysplasia of the hip
gradually replacing the old term 'congenital dislocation of the hip' (CDH). It affects around 1-3% of newborns.
93
Risk factors of developmental dysplasia
female sex: 6 times greater risk breech presentation positive family history firstborn children oligohydramnios birth weight > 5 kg congenital calcaneovalgus foot deformity
94
Screening for DDH
Ultrasound patients who have * first degree relative with he of hip problem in early life * breech position at or after 36 weeks gestation * multiple pregnancy all infants are screened at both the newborn check and also the six-week baby check using the Barlow and Ortolani tests
95
Clinical examination for DDH
Barlow test: attempts to dislocate an articulated femoral head Ortolani test: attempts to relocate a dislocated femoral head * leg symmetry *level of knees when hips and knees are bilaterally flexed * restricted abduction of hip flexion
96
Imaging of DDH
ultrasound is generally used to confirm the diagnosis if clinically suspected however, if the infant is > 4.5 months then x-ray is the first line investigation
97
Management of DDH
most unstable hips will spontaneously stabilise by 3-6 weeks of age Pavlik harness (dynamic flexion-abduction orthosis) in children younger than 4-5 months older children may require surgery
98
Spina bifida occulta
incidental finding overlying skin lesion such as tuft of hair, birth mark or sinus Involvement of the spinal cord may result in neurological defects
99
Meningocele
Cyst of meninges and cerebrospinal fluid No neurological involvement Good prognosis following surgical correction
100
Myelomeningocele
Cyst of meninges and cerebrospinal fluid but also involving the spinal cord nerves Often results in bladder and bowel incontinence, paraparesis of the legs and hydrocephalus (associated Arnold-Chiari malformation)
101
Anencephaly
Absence of cranium and brain. Affected babies are stillborn
102
AFP
15-27 weeks Neural tubes detected by routine ultrasound at 18-20 weeks
103
Prevention of neural tube defects
folic acid 0.4 mg per day from before conception and until the end of the first trimester
104
When 5mg folic acid needed
family history of neural tube defects patients taking anti-epileptic medications diabetes mellitus coeliac disease (or other malabsorption states) sickle cell anaemia
105
Transient synovitis
Acute onset Usually accompanies viral infections, but the child is well or has a mild fever More common in boys, aged 2-12 years
106
Septic arthritis/osteomyelitis
Unwell child, high fever
107
Juvenile idiopathic arthritis
Limp may be painless
108
DDH
Usually detected in neonates 6 times more common in girls
109
Perthes disease
More common at 4-8 years Due to avascular necrosis of the femoral head
110
Slipped upper femoral epiphysis
10-15 years - Displacement of the femoral head epiphysis postero-inferiorly
111
haematogenous osteomyelitis
results from bacteraemia is usually monomicrobial most common form in children vertebral osteomyelitis is the most common form of haematogenous osteomyelitis in adults risk factors include: sickle cell anaemia, intravenous drug user, immunosuppression due to either medication or HIV, infective endocarditis
112
non-haematogenous osteomyelitis:
results from the contiguous spread of infection from adjacent soft tissues to the bone or from direct injury/trauma to bone is often polymicrobial most common form in adults risk factors include: diabetic foot ulcers/pressure sores, diabetes mellitus, peripheral arterial disease
113
Osteomyelitis causative agent
Staph aureus sickle-cell anaemia where Salmonella species predominate
114
Osteomyelitis investigation
MRI
115
Management of osteomyelitis
flucloxacillin for 6 weeks clindamycin if penicillin-allergic
116
Stages of Perth’s disease
117
Features of Perthes’ disease
hip pain: develops progressively over a few weeks limp stiffness and reduced range of hip movement x-ray: early changes include widening of joint space, later changes include decreased femoral head size/flattening
118
Diagnosis of Perthes disease
plain x-ray technetium bone scan or magnetic resonance imaging if normal x-ray and symptoms persist
119
Complications of Perthes disease
osteoarthritis premature fusion of the growth plates
120
Management of Perthes disease
To keep the femoral head within the acetabulum: cast, braces If less than 6 years: observation Older: surgical management with moderate results Operate on severe deformities
121
Prognosis of Perthes disease
Most cases will resolve with conservative management. Early diagnosis improves outcomes.
122
Perthes disease
degenerative condition affecting the hip joints of children, typically between the ages of 4-8 years. It is due to avascular necrosis of the femoral head, specifically the femoral epiphysis. Impaired blood supply to the femoral head causes bone infarction
123
Transient synovitis
acute hip pain following a recent viral infection. It is the commonest cause of hip pain in children. The typical age group is 3-8 years
124
Features of transient synovitis
limp/refusal to weight bear groin or hip pain a low-grade fever is present in a minority of patients high fever should raise the suspicion of other causes such as septic arthritis
125
TS red flag
Fever
126
Management of TS
- self limiting - rest and analgesia
127
Chronic fatigue syndrome
3 months of disabling fatigue affecting mental and physical function more than 50% of the time in the absence of other disease which may explain symptoms
128
Epidemiology of chronic fatigue syndrome
more common in females past psychiatric history has not been shown to be a risk factor
129
Features of chronic fatigue syndrome
sleep problems, such as insomnia, hypersomnia, unrefreshing sleep, a disturbed sleep-wake cycle muscle and/or joint pains headaches painful lymph nodes without enlargement sore throat cognitive dysfunction, such as difficulty thinking, inability to concentrate, impairment of short-term memory, and difficulties with word-finding physical or mental exertion makes symptoms worse general malaise or 'flu-like' symptoms dizziness nausea palpitations
130
Chronic fatigue investigation
FBC, U&E, LFT, glucose, TFT, ESR, CRP, calcium, CK, ferritin, coeliac screening and also urinalysis
131
Criteria for CFS
132
management of CfS
refer to a specialist CFS service energy management a self-management strategy that involves a person with ME/CFS managing their activities to stay within their energy limit, with support from a healthcare professional physical activity and exercise do not advise people with ME/CFS to undertake exercise that is not part of a programme overseen by an ME/CFS specialist team cognitive behavioural therapy NICE stress this is 'supportive' rather than curative for CFS
133
Fibromyalgia
syndrome characterised by widespread pain throughout the body with tender points at specific anatomical sites. The cause of fibromyalgia is unknown.
134
Epidemiology of fibromyalgia
women are around 5 times more likely to be affected typically presents between 30-50 years old
135
Features of fibromyalgia
chronic pain: at multiple site, sometimes 'pain all over' lethargy cognitive impairment: 'fibro fog' sleep disturbance, headaches, dizziness are common
136
Management of fibromyalgia
explanation aerobic exercise: has the strongest evidence base cognitive behavioural therapy medication: pregabalin, duloxetine, amitriptyline
137
Diagnosis of fibromyalgia
classification criteria which lists 9 pairs of tender points on the body. If a patient is tender in at least 11 of these 18 points it makes a diagnosis of fibromyalgia more likely
138
Features of influenza
fever greater than 38ºC myalgia lethargy headache rhinitis sore throat cough diarrhoea and vomiting
139
Management of influenza
Self limiting
140
When to use antivirals for influenza
1) The patient is in an at-risk group or is felt to be at risk of developing a serious complication > 65 years old pregnant women chronic disease of respiratory, cardiac, renal, hepatic or neurological nature diabetes immunosuppression morbid obesity. 2) There is circulating influenza nationally this would mean typically the winter months 3) The patient is able to start treatment within 48 hours from the onset of symptoms
141
Antivirals used for influenza
First line: oseltamivir Second line: zanamivir
142
Osteomalacia
**softening of the bones secondary to low vitamin D** levels that in turn lead to decreased bone mineral content. If this occurs in growing children it is referred to as rickets, with the term osteomalacia preferred for adults.
143
What crystal is associated with pseudogout?
calcium pyrophosphate
144
What crystal is assoicated with gout?
uric acid
145
gout vs pseudogout
* **Gout**- negative birefringence * **Pseudgout**- weak positive birefirngence
146
risk factors for gout
* Male sex * Age over 50 years * Family history of gout * Inherited syndrome with uric acid overproduction (eg. Lesch–Nyhan syndrome) ---------------------------------------------- * Obesity * Hypertension * Chronic kidney disease * Diabetes * Metabolic syndrome * Medications (eg. thiazide diuretics, ACE inhibitors and aspirin)
147
What causes triggers of gout?
* Seafood/protein binges – eating lots of high-protein foods raises levels of uric acid * Chemotherapy – increases cell breakdown * Trauma and surgery – increases cell breakdown * Alcohol excess * Intercurrent illness * Medications that interfere with the handling of uric acid (eg. **allopurinol**)
148
what are the symptoms of gout? (5)
* Excruciating, sudden, burning pain in the affected joint * Swelling, redness, warmth and stiffness in the affected joint * Asymmetric joint distribution * Mild fever * Tachycardia as a transient sympathetic response to the pain of an acute attack
149
What is the gender ratio of systemic lupus erythematosus (SLE) prevalence?
F:M = 9:1
150
In which populations is SLE more common?
Afro-Caribbeans and Asian communities
151
What is the typical age of onset for systemic lupus erythematosus?
20-40 years
152
How much has the incidence of SLE risen in the past 50 years?
3 fold
153
What type of hypersensitivity reaction is SLE?
Type 3 hypersensitivity reaction
154
Which HLA types are associated with SLE?
HLA B8, DR2, DR3
155
What is a common pathophysiological feature of SLE?
Immune system dysregulation leading to immune complex formation
156
What organs can be affected by immune complex deposition in SLE?
* Skin * Joints * Kidneys * Brain
157
What are common general features of SLE?
* Fatigue * Fever * Mouth ulcers * Lymphadenopathy
158
Describe the malar rash associated with SLE.
Butterfly rash that spares the nasolabial folds
159
What is the most common cardiac manifestation of SLE?
Pericarditis
160
What type of glomerulonephritis is most common in SLE?
Diffuse proliferative glomerulonephritis
161
What is the sensitivity and specificity of anti-dsDNA antibodies in SLE?
Highly specific (> 99%), less sensitive (70%)
162
What is the treatment of choice for SLE?
Hydroxychloroquine
163
What is the management for lupus nephritis?
* Glucocorticoids * Mycophenolate or cyclophosphamide
164
How is lupus nephritis classified according to WHO?
* Class I: Normal kidney * Class II: Mesangial glomerulonephritis * Class III: Focal proliferative glomerulonephritis * Class IV: Diffuse proliferative glomerulonephritis * Class V: Diffuse membranous glomerulonephritis * Class VI: Sclerosing glomerulonephritis
165
What is the key finding in renal biopsy for class IV lupus nephritis?
Endothelial and mesangial proliferation with a 'wire-loop' appearance
166
What are the common features of polymyalgia rheumatica (PMR)?
* Age > 60 years * Rapid onset * Morning stiffness in proximal limb muscles
167
What are the typical inflammatory markers in PMR?
ESR > 40 mm/hr
168
What is the first-line treatment for PMR?
Prednisolone 15mg/od
169
What are the risk factors for osteoarthritis (OA) of the hip?
* Increasing age * Female gender * Obesity * Developmental dysplasia of the hip
170
What is a red flag feature in OA of the hip?
Rest pain, night pain, morning stiffness > 2 hours
171
What is the first-line investigation for OA if clinical diagnosis is uncertain?
Plain x-rays
172
What is the definitive treatment for severe OA?
Total hip replacement
173
What is greater trochanteric pain syndrome also known as?
Trochanteric bursitis
174
What are the features of fibromyalgia?
* Chronic pain * Lethargy * Cognitive impairment ('fibro fog') * Sleep disturbance
175
What is the typical age range for fibromyalgia presentation?
30-50 years
176
What are the common causes of compartment syndrome?
* Fractures * Ischemia reperfusion injury
177
What is the diagnostic measurement for compartment syndrome?
Intracompartmental pressure > 20 mmHg is abnormal; > 40 mmHg is diagnostic
178
What is the primary feature of gout?
Deposition of monosodium urate monohydrate in the synovium
179
What are common drug causes of gout? (6)
* Diuretics * Ciclosporin * Alcohol * Cytotoxic agents * Pyrazinamide * Low-dose aspirin
180
What joint is most commonly affected in gout?
1st metatarsophalangeal (MTP) joint
181
What uric acid level supports a diagnosis of gout?
Uric acid level ≥ 360 umol/L
182
What is the first-line treatment for acute gout?
NSAIDs or colchicine
183
What is the first-line urate-lowering therapy for gout?
Allopurinol
184
What is the initial dose of allopurinol?
100 mg od
185
What is the target serum uric acid level for gout management?
Aim for a serum uric acid of < 360 µmol/l ## Footnote A lower target of < 300 µmol/l may be considered for patients with tophi, chronic gouty arthritis, or frequent flares.
186
What should be considered when starting allopurinol in patients with gout?
Colchicine cover should be considered; NSAIDs can be used if colchicine cannot be tolerated ## Footnote BSR guidelines suggest this may need to continue for 6 months.
187
What is the second-line agent when allopurinol is not tolerated or ineffective?
Febuxostat ## Footnote Febuxostat is also a xanthine oxidase inhibitor.
188
What is uricase and its function?
Uricase is an enzyme that catalyzes the conversion of urate to allantoin ## Footnote It is present in certain mammals but not humans.
189
What is pegloticase and how is it administered?
Pegloticase is a polyethylene glycol modified mammalian uricase given as an infusion once every two weeks ## Footnote It achieves rapid control of hyperuricemia in patients with severe gout.
190
What lifestyle modifications should be made for gout management?
* Reduce alcohol intake * Lose weight if obese * Avoid food high in purines (e.g., liver, kidneys, seafood, oily fish, yeast products)
191
What is a specific uricosuric agent that may be suitable for patients with hypertension?
Losartan ## Footnote It has a specific uricosuric action.
192
Which vitamin may help decrease serum uric acid levels?
Increased vitamin C intake ## Footnote This can be through supplements or normal diet.
193
What causes gout?
Gout is caused by the deposition of monosodium urate monohydrate in the synovium due to chronic hyperuricaemia (uric acid > 0.45 mmol/l)
194
What are common causes of decreased excretion of uric acid?
* Diuretics * Chronic kidney disease * Lead toxicity
195
What can increase the production of uric acid? (3)
* Myeloproliferative/lymphoproliferative disorder * Cytotoxic drugs * Severe psoriasis
196
What is Lesch-Nyhan syndrome?
A condition caused by hypoxanthine-guanine phosphoribosyl transferase (HGPRTase) deficiency ## Footnote It is X-linked recessive and features gout, renal failure, neurological deficits, learning difficulties, and self-mutilation.
197
True or False: Aspirin in a dose of 75-150 mg significantly affects plasma urate levels.
False ## Footnote The British Society for Rheumatology recommends it should be continued for cardiovascular prophylaxis.
198
What is hyperuricaemia and what can it be associated with?
Increased levels of uric acid due to increased cell turnover or reduced renal excretion ## Footnote It may be associated with hyperlipidaemia, hypertension, and metabolic syndrome.
199
What is pseudogout caused by?
Deposition of calcium pyrophosphate dihydrate crystals in the synovium ## Footnote It is also referred to as acute calcium pyrophosphate crystal deposition disease.
200
What are common features of pseudogout?
* Knee, wrist, and shoulders most commonly affected * Weakly-positively birefringent rhomboid-shaped crystals on joint aspiration * X-ray shows chondrocalcinosis
201
What is the management strategy for pseudogout?
* Aspiration of joint fluid to exclude septic arthritis * NSAIDs or steroids as for gout
202
Fibromyalgia tender pints
Occiput (2 points: left and right) Lower cervical spine (2 points: left and right) Trapezius muscle (2 points: left and right) Supraspinatus muscle (2 points: left and right) Second rib (2 points: left and right) Lateral epicondyle (2 points: left and right) Gluteal muscles (2 points: left and right) Greater trochanter (2 points: left and right) Medial fat pad of the knee (2 points: left and right)